Similar articles for PMID: 31320330

Year	Number of Results
1870	1
1890	1
1907	1
1917	1
1933	5
1934	4
1961	1
1962	2
1978	1
1989	1
1990	1
1993	1
1994	1
1995	1
1998	1
1999	1
2002	3
2003	2
2004	4
2005	4
2006	5
2007	8
2008	2
2009	4
2010	3
2011	1
2012	4
2013	6
2014	3
2015	3
2016	3
2017	5
2018	4
2019	8
2020	2
2022	3
2023	1
2024	0

1

The impact of the introduction of a formulary into a large Canadian private drug plan: an interrupted time-series analysis.

Cassels A, Law MR. Cassels A, et al. CMAJ Open. 2019 Jul 18;7(3):E472-E477. doi: 10.9778/cmajo.20180124. Print 2019 Jul-Sep. CMAJ Open. 2019. PMID: 31320330 Free PMC article.

2

The impact of OHIP+ pharmacare on use and costs of public drug plans among children and youth in Ontario: a time-series analysis.

Miregwa BN, Holbrook A, Law MR, Lavis JN, Thabane L, Dolovich L, Wilson MG. Miregwa BN, et al. CMAJ Open. 2022 Sep 27;10(3):E848-E855. doi: 10.9778/cmajo.20210295. Print 2022 Sep-Oct. CMAJ Open. 2022. PMID: 36167420 Free PMC article.

3

Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.

Johnson JT, Neill KK, Davis DA. Johnson JT, et al. J Manag Care Pharm. 2011 Apr;17(3):200-12. doi: 10.18553/jmcp.2011.17.3.200. J Manag Care Pharm. 2011. PMID: 21434697 Free PMC article.

4

Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.

Shirneshan E, Kyrychenko P, Matlin OS, Avila JP, Brennan TA, Shrank WH. Shirneshan E, et al. J Clin Pharm Ther. 2016 Feb;41(1):64-9. doi: 10.1111/jcpt.12349. Epub 2016 Jan 18. J Clin Pharm Ther. 2016. PMID: 26778812

5

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG. Huskamp HA, et al. Arch Gen Psychiatry. 2005 Apr;62(4):435-41. doi: 10.1001/archpsyc.62.4.435. Arch Gen Psychiatry. 2005. PMID: 15809411 Free PMC article.

6

Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.

Yokoyama K, Yang W, Preblick R, Frech-Tamas F. Yokoyama K, et al. J Manag Care Pharm. 2007 Apr;13(3):235-44. doi: 10.18553/jmcp.2007.13.3.235. J Manag Care Pharm. 2007. PMID: 17407390 Free PMC article.

7

Formulary management in the Department of Defense.

Trice S, Devine J, Mistry H, Moore E, Linton A. Trice S, et al. J Manag Care Pharm. 2009 Mar;15(2):133-46. doi: 10.18553/jmcp.2009.15.2.133. J Manag Care Pharm. 2009. PMID: 19236127 Free PMC article.

8

Design, implementation, and first-year outcomes of a value-based drug formulary.

Sullivan SD, Yeung K, Vogeler C, Ramsey SD, Wong E, Murphy CO, Danielson D, Veenstra DL, Garrison LP, Burke W, Watkins JB. Sullivan SD, et al. J Manag Care Spec Pharm. 2015 Apr;21(4):269-75. doi: 10.18553/jmcp.2015.21.4.269. J Manag Care Spec Pharm. 2015. PMID: 25803760 Free PMC article.

9

Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.

Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD. Yeung K, et al. Med Care. 2017 Feb;55(2):191-198. doi: 10.1097/MLR.0000000000000630. Med Care. 2017. PMID: 27579915 Free PMC article.

10

Cost shifting and timeliness of drug formulary decisions in atlantic Canada.

Scobie AC, Mackinnon NJ. Scobie AC, et al. Healthc Policy. 2010 Feb;5(3):100-14. Healthc Policy. 2010. PMID: 21286272 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year